The Rural Service and Workforce Corps Act creates a program offering scholarships, tuition assistance, student loan repayment, stipends, and relocation incentives to individuals who commit to working for three years in rural areas with critical workforce shortages. It prioritizes filling gaps in health care (including primary care and behavioral health), skilled trades (like electricians and plumbers), energy infrastructure (lineworkers and renewable technicians), and utilities (water operators and broadband technicians). Designated areas include persistent poverty counties, health professional shortage areas, and regions with Native American communities. Employers meeting wage and training standards - such as public agencies, nonprofits, and tribal organizations - can participate to recruit and retain workers in these targeted sectors.
The ACE Agriculture Act reauthorizes and expands the Agricultural Research, Extension, and Teaching Policy Act's AGARDA program, directly affecting USDA agricultural research initiatives and the scientists managing them. It increases annual funding from $50 million to $100 million for fiscal years 2027-2032 and broadens research priorities to include water conservation, greenhouse gas reduction, pest resilience, and export competitiveness. The bill removes "pilot" references throughout, clarifies reporting structures (requiring the AGARDA Director to report to the Chief Scientist), and allows flexible use of existing USDA personnel authorities. This creates a more permanent, well-funded framework for advancing agricultural technology research within the Department of Agriculture.
This joint resolution seeks to prohibit a specific foreign military sale of defense articles and services to the Government of Israel. It directly affects the proposed transaction by invoking the Congressional Review Act to disapprove the sale of 10,000 BLU-111 500-pound general purpose bombs and related logistics support. The bill uses the statutory authority under the Arms Export Control Act to block the sale without requiring new legislation. If passed, it would prevent the transfer of these specific weapons and associated services to Israel.
This joint resolution seeks to prohibit the licensing of specific defense articles and services to Israel, including 5,000 Small Diameter Bomb Weapon Systems. The bill directly affects the proposed arms sales notification submitted to Congress on March 12, 2026, under the Arms Export Control Act. By passing this resolution, Congress would exercise its authority to disapprove the licensing of these particular defense items. The measure is currently referred to the Committee on Foreign Relations for consideration.
This resolution supports designating March 21, 2026, as National Women in Agriculture Day to recognize the contributions of women in the agricultural sector. It highlights that over 1.2 million women in the U.S. are agricultural producers, representing more than one-third of all producers, and notes their significant economic impact through farm sales and roles in research, education, and agribusiness. The measure encourages citizens to acknowledge and celebrate women working in agriculture during National Ag Week, aligning with the 2026 International Year of the Woman Farmer.
This bill, titled the No Bailout for Crypto Act, prohibits the U.S. government from providing financial assistance to companies and systems involved in digital asset activities to prevent their failure or bankruptcy. It specifically bars Federal agencies from using emergency liquidity facilities, the Exchange Stabilization Fund, or other taxpayer resources to support digital asset intermediaries, decentralized finance protocols, or regulated financial service providers operating in the digital asset space. The legislation aims to establish a clear rule that digital asset market participants cannot receive taxpayer-funded bailouts, while maintaining the Federal Reserve's existing authority to lend to traditional depository institutions.
This bill creates a new tax credit for employers who increase the wages they pay to child care workers. It directly affects businesses that operate eligible child care facilities, which are defined as places serving at least six children and following state regulations. To qualify, an employer must pay higher average hourly wages to child care staff in the current year compared to the previous year, and the credit amount is based on the increase in those wages. The credit is generally 5% of the wage increase, but rises to 7% for facilities located in rural areas. Employers can choose to opt out of the credit if they prefer, and the bill also clarifies how the credit interacts with other tax provisions to prevent double benefits.
S 3812, the WORK to Save Lives Act, requires the Occupational Safety and Health Administration (OSHA) to issue guidance for most private employers on acquiring opioid overdose reversal medication and training employees annually, while mandating that all federal agencies (including the Veterans Health Administration) must acquire such medication and provide annual employee training. The bill directly affects federal agencies as mandatory participants and private employers (excluding the U.S. Postal Service) as recipients of non-mandatory guidance. Key provisions include a 270-day deadline for OSHA to issue these rules after the bill’s enactment. The law aims to improve workplace safety by making overdose reversal tools more accessible without imposing direct penalties on private businesses.
This bill creates a new grant program to help schools access naloxone for opioid overdose emergencies. It directly affects public and private elementary and secondary schools by requiring them to certify they have trained staff (like nurses or designated personnel), maintain accessible naloxone supplies, and have a plan for trained staff on-site during school hours. Schools must also confirm their state provides adequate legal protection for staff who administer naloxone. The grants, funded through the Public Health Service Act, support these requirements to enable immediate emergency treatment of opioid overdoses in school settings.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
S 2287, the Palliative Care and Hospice Education and Training Act, establishes federal funding to expand training for health professionals in palliative and hospice care. The bill creates multiple programs including grants for education programs, fellowships for faculty to gain specialized training, and career incentive awards for students pursuing palliative care specialties. It prioritizes training in rural and underserved areas, for pediatric populations, and for racial and ethnic minorities. The bill authorizes $15 million annually through 2030 to build a more skilled palliative care workforce for patients with serious or life-threatening illnesses.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
